semaglutide weight loss programs aurora Wegovy® in GLP-1s in Aurora, CO |

GLP-1 receptor agonists such as semaglutide are primarily designed for blood sugar control and weight management, but emerging research suggests indirect effects on stress hormone pathways

Fernando lvarez Guisasola y Xavier Cos Claramunt

Ozempic, the GLP-1 drug initially approved by the FDA to treat type 2 diabetes, was recently OK'd to also help reduce risks linked to chronic kidney disease.

The real disruption won't announce itself

TUESDAY, July 15, 2025 (HealthDay News) Folks using GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, a new study says.P

The starting dose of Wegovy is 0.25 mg once weekly for the first four weeks, which helps your body adjust and minimises gastrointestinal side effects. The dose is then gradually increased every four weeks through 0.5 mg, 1 mg, and 1.7 mg until reaching the maintenance dose of 2.4 mg once weekly at week 17. Never skip the escalation schedule without guidance from your prescriber